3 ASX Health Care Shares Paying Healthy Dividends

Low interest rates have made it impossible to generate a reasonable income from bank accounts and term deposits. So, here are three health care companies paying big dividends right now.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

Low interest rates have made it impossible to generate a reasonable income from bank accounts and term deposits. So, here are three health care companies paying big dividends right now.

Regis Healthcare Ltd (ASX: REG)

Regis Healthcare is one of Australia’s largest providers of aged care services with more than 6,000 residents calling Regis home. Across Australia, Regis owns and operates 63 aged care facilities that offer a range of healthcare support services including respite care, specialist dementia care and palliative care.

The Regis share price has fallen recently following its FY19 results, which showed the company was impacted by the recent aged care Royal Commission. Regis reported an 18% cut to dividends but the shares still trade on a fully-franked trailing dividend yield of 5.56%.

The Rask Finance video below explains dividends:

Although the dividend looks attractive now, the question is whether dividends can be maintained with FY20 results also expected to be impacted by the Royal Commission. I don’t know if I would buy today, but this is one company worth watching.

Estia Health Ltd (ASX: EHE)

Estia Health is a competitor of Regis and has been an aged care provider in Australia for nearly 50 years. The company currently operates 69 facilities across Australia.

Estia Health fared better than Regis in its FY19 result

online pharmacy purchase aciclovir online with best prices today in the USA

, reporting 7% revenue growth and net profit after tax (NPAT) in-line with the FY18 result. Importantly, Estia also reported a higher occupancy rate than Regis across its centres (93.6% versus 92.7%).

Estia managed to maintain its fully-franked dividend of 15.8 cents per share for the year, giving shares a trailing dividend yield of 6.08%.

Comparing Regis and Estia, my pick would have to be Estia right now.

Australian Pharmaceutical Industries Ltd (ASX: API)

Moving away from aged care, Australian Pharmaceuticals Industries is the parent company of Priceline Pharmacy, Soul Pattinson Chemist and Pharmacist Advice. Services provided by API include wholesale product delivery, retail services, marketing programs and business advisory services.

API reported modest growth in 1H19, with gross profit up 9.5% despite a 1.6% decline in revenue. Earnings before interest and tax (EBIT) grew by 5.8% and the fully-franked interim dividend was increased from 3.5 cents per share to 3.75 cps.

At the current share price, API shares provide a trailing dividend yield of 5.98%.

My Take

These dividend yields of around 6% are difficult to find on the ASX and typically come from banks. These three companies, although they have faced some challenges over the past year, all have growth opportunities with a growing and ageing population. Pleasingly, Estia and API, in particular, look like they will be able to maintain current dividends.

There are certainly risks to consider, especially around the impacts of the Royal Commission for Regis and Estia, but these are three companies that I think could be worth considering for their dividends.

For more proven dividend companies, have a look at the free report below.

[ls_content_block id=”14945″ para=”paragraphs”]

Disclosure: At the time of writing, Max does not own shares in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.